John Whelan serves as Executive at AP PHARMA INC /DE/, where they oversee executive responsibilities. Since joining the company, John Whelan has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 18, 2013 involved exercising options for 254,088 shares valued at $66.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 18, 2013 | APPA | $66.1K | Option Exercise | 254,088 | $0.26 | Discretionary |
John Whelan currently holds 254,088 shares of AP PHARMA INC /DE/ (APPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Whelan has been a net neutral trader of APPA stock. They have purchased $0 and sold $0 worth of shares.
John Whelan's most recent insider trade was on Jul 18, 2013, when they sold 254,088 shares at $0.26 per share.
Get notified when new Form 4 filings are submitted